Skip to main content
. Author manuscript; available in PMC: 2011 Mar 6.
Published in final edited form as: Arch Pathol Lab Med. 2010 Nov;134(11):1702–1705. doi: 10.5858/2009-0664-oar1.1

Table 3.

Coexpression pattern of PAX5 with c-Met or p-c-Met

Tumor
Type		 PAX5 + c-Met PAX5 + p-c-Met PAX5 + c-Met or p-c-Met
Positive Strong Positive Strong Positive Strong
TC
(n=38)		 11
(29%)		 0
(0%)		 10
(26%)		 0
(0%)		 11
(29%)		 0
(0%)
AC
(n=6)		 4
(67%)		 1
(17%)		 4
(67%)		 1
(17%)		 4
(67%)		 1
(17%)
SCLC
(n=34)		 26
(76%)		 9
(26%)		 28
(82%)		 9
(26%)		 28
(82%)		 11
(32%)
LCNEC
(n=11)		 7
(64%)		 1
(9%)		 8
(73%)		 1
(9%)		 8
(73%)		 2
(18%)

TC, typical carcinoid; AC, atypical carcinoid; SCLC, small cell lung carcinoma; LCNEC, large cell neuroendocrine carcinoma